Greif Vs. Aligos Therapeutics Industry Stock Comparison

Sell

44

GEF
Greif

Last Price:

$60.99

Seasonality Move:

2.06%

Buy

69

ALGS
Aligos Therapeutics

Last Price:

$43.44

Seasonality Move:

-17.17%

Sell

44

Greif (GEF) is a Sell

Is Greif a Buy, Sell or Hold?

The current Greif [GEF] share price is $61.03. The Score for GEF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
GEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

69

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GEF Stock Price Chart

What is Greif's stock price today?

The Greif share price today is $61.03

The current trend is relatively stagnant and GEF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $43.42

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

GEF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.89	Sell
Relative Strength Index (14 RSI):	34.29	Sell
Chaikin Money Flow:	133808	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(61.12 - 69.6)	Sell
Bollinger Bands (100):	(60.39 - 67.39)	Sell

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.14	Buy
Relative Strength Index (14 RSI):	74.33	Buy
Chaikin Money Flow:	210748	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(27.82 - 40.1)	Buy
Bollinger Bands (100):	(6.77 - 28.07)	Buy

GEF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	61.05	Sell
20-day SMA:	63.89	Sell
50-day SMA:	65.87	Sell
200-day SMA:	63.35	Sell
8-day EMA:	61.33	Sell
20-day EMA:	63.29	Sell
50-day EMA:	64.67	Sell
200-day EMA:	64.04	Sell

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	40.78	Buy
20-day SMA:	36.11	Buy
50-day SMA:	23.97	Buy
200-day SMA:	16.97	Buy
8-day EMA:	40.32	Buy
20-day EMA:	35.95	Buy
50-day EMA:	27.43	Buy
200-day EMA:	19.22	Buy

Greif Earnings Growth & GEF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.48 per share, an increase this year of $0.12 per share, and an increase next year of $1.10 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Greif Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):